Boscarino G, Parente E, Minelli F, Ferrante Alberto, Snider F
G Chir. 2014 Jan-Feb;35(1-2):47-51.
Objectives. Carotid Body Tumor (CBT) is a rare lesion of the neuroendocrine system but it is the most common form of head and neck paraganglioma (PGL). Our objective is to discuss the optimal management of these lesions to provide the best outcome of patients treated by surgical resection. Patients and Methods. A retrospective evaluation was obtained by review of the records of 20 patients with 26 CBT treated at our institution between 2000 and 2012. Primary tumor characteristics, diagnostic protocols, surgical treatment, short and long-term outcomes were collected and analyzed. Results. A total of 26 CBTs resections were performed on 20 patients; the age range was 21-89 years. There was a female prevalence (14 women-80% and 6 men-20%). Familial cases occurred in 6 patients (30%); of these, 3 patients had bilateral lesions and 1 patient multiple paragangliomas. In all cases no lymph node metastasis was found. All lesions were grouped into three groups according to the latero-lateral diameter: Group I < 3 cm; Group II 3<>5cm; Group III >5cm. All patients were managed by surgical resection of the CBT. There were no operative deaths. Overall we found transitory neurological impairment in 15,3% and permanent neurological deficit in 7,6% of cases. No complications occurred in all resections of Group I tumors. In Group II only 1 resection was followed by dysphonia by recurrent nerve palsy (after vagal nerve en-bloc resection). In Group III only 1 resection was followed by permanent vagus nerve palsy. Conclusions. Surgical removal of the tumor is the only treatment that can ensure a complete eradication of the disease. Family screening is of great importance in patients with hereditary forms. Careful preoperative planning of surgical procedure by integrated diagnostic imaging and a full mastery of the surgical technique can minimize the risk of the most common postoperative complications. Lifelong follow-up is mandatory to make early diagnosis of recurrent disease.
目的。颈动脉体瘤(CBT)是神经内分泌系统的一种罕见病变,但它是头颈部副神经节瘤(PGL)最常见的形式。我们的目的是讨论这些病变的最佳管理方法,以使接受手术切除治疗的患者获得最佳预后。患者与方法。通过回顾2000年至2012年在我院接受治疗的20例患有26个CBT的患者的记录进行回顾性评估。收集并分析了原发肿瘤特征、诊断方案、手术治疗、短期和长期结果。结果。对20例患者共进行了26次CBT切除术;年龄范围为21 - 89岁。女性患病率较高(14名女性 - 80%,6名男性 - 20%)。6例患者(30%)为家族性病例;其中,3例患者为双侧病变,1例患者有多发性副神经节瘤。所有病例均未发现淋巴结转移。根据左右径将所有病变分为三组:I组<3cm;II组3<>5cm;III组>5cm。所有患者均通过手术切除CBT进行治疗。无手术死亡病例。总体而言,我们发现15.3%的病例出现短暂性神经功能障碍,7.6%的病例出现永久性神经功能缺损。I组肿瘤的所有切除均未发生并发症。II组仅1例切除术后因喉返神经麻痹出现声音嘶哑(迷走神经整块切除术后)。III组仅1例切除术后出现永久性迷走神经麻痹。结论。手术切除肿瘤是唯一能够确保彻底根除疾病的治疗方法。对于遗传性形式的患者,家族筛查非常重要。通过综合诊断成像进行仔细的术前手术规划以及全面掌握手术技术可以将最常见术后并发症的风险降至最低。必须进行终身随访以便对复发性疾病进行早期诊断。